Skip to content
Open access

Survival and Mortality Predictors in Prostate Cancer: A Retrospective Cohort of 10 556 Brazilian Patients

Aug 2026 · Cancer Reports · Vol 9 · 0 citations · 50 references
Medicine

TL;DR

This study aimed to estimate survival and investigate factors associated with PCa‐specific mortality among men treated within the oncology care network of a Brazilian state.

Abstract

Prostate cancer (PCa) remains one of the most frequently diagnosed malignancies worldwide and represents a major contributor to premature mortality among men. This study aimed to estimate survival and investigate factors associated with PCa‐specific mortality among men treated within the oncology care network of a Brazilian state.

Read PDF

Similar papers

Open access Sep 2026

Cancer Patients Mortality From Other Causes: A European Population‐Based Study

Analysis of mortality from all causes other than the index cancer among cancer patients compared to the general population finds elevated mortality among cancer patients compared to the general population.

Gemma Gatta, R. Capocaccia, S. Rossi et al. · 0 citations
Open access Aug 2026

Development of a Prognostic Survival Risk Score for Lung Cancer Patients With Type 2 Diabetes Mellitus: A Territory‐Wide Retrospective Cohort Study

Lung cancer is a leading cause of cancer‐related mortality, and its prognosis is often affected by comorbidities such as type 2 diabetes mellitus (T2DM). This study aimed to identify survival risk factors for lung cancer patients with T2DM, evaluate the predictive models, and develop a risk score system for survival pr...

Chen-Wen Zhong, Jun-Jie Huang, Zhao-Jun Li et al. · 0 citations
Open access Sep 2026

Effect of demographic characteristics on the outcome of prostate cancer salvage radiotherapy: Analysis from a randomized controlled trial

This study investigated the impact of advanced molecular imaging, race, socioeconomic status, and metabolic dysregulation on the outcome of salvage radiotherapy (sRT) for prostate cancer recurrence in a clinical trial setting.

I. Lawal, A. Jani, Subir Goyal et al. · 0 citations
Open access Sep 2026

Cancer‐Control Outcomes of Japanese Vs. German Metastatic Hormone‐Sensitive Prostate Cancer Patients: A Real‐World Cross‐Country Comparison of Patients Undergoing Combination Therapies

Differences in tumor biology, ethnicities, and healthcare structures across populations may contribute to variability in oncologic outcomes. This study compared baseline characteristics and oncologic outcomes of Japanese and German metastatic hormone‐sensitive prostate cancer (mHSPC) patients.

Mike Wenzel, Keiichiro Miyajima, M. Filzmayer et al. · 1 citation
Open access Sep 2026

Prognostic Value of Different Biological Age Estimation Methods in Breast Cancer Patients: A Population‐Based Cohort Study Using NHANES 1999–2020

Breast cancer is the most common malignancy in women, and advanced biological ageing correlates with increased incidence. However, the prognostic value of comprehensive biological age biomarkers remains unclear. This study aimed to investigate the association between composite biological age indices and mortality in br...

Guo-Dong Chen, Wei Lin, Xue-Liang Cheng et al. · 0 citations
Open access Sep 2026

Impact of Clinicopathological and Institutional Factors on the Clinical Courses of Patients With Localized Prostate Cancer Initially Managed by Active Surveillance: An Analysis of Nationwide Real‐World Data From Japan

To investigate active surveillance (AS) continuation rates and associated clinical and institutional factors in Japanese patients with localized prostate cancer.

Mizuki Onozawa, M. Shiota, T. Kawai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.